543748 logo

Aarti Pharmalabs BSE:543748 Stock Report

Last Price

₹739.80

Market Cap

₹67.0b

7D

-0.2%

1Y

66.8%

Updated

16 Mar, 2025

Data

Company Financials

Aarti Pharmalabs Limited

BSE:543748 Stock Report

Market Cap: ₹67.0b

543748 Stock Overview

Engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. More details

543748 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends2/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Aarti Pharmalabs Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Aarti Pharmalabs
Historical stock prices
Current Share Price₹739.80
52 Week High₹837.00
52 Week Low₹429.50
Beta-0.63
1 Month Change2.75%
3 Month Change22.72%
1 Year Change66.81%
3 Year Changen/a
5 Year Changen/a
Change since IPO96.16%

Recent News & Updates

Recent updates

Shareholder Returns

543748IN PharmaceuticalsIN Market
7D-0.2%-1.0%-1.8%
1Y66.8%10.1%-0.5%

Return vs Industry: 543748 exceeded the Indian Pharmaceuticals industry which returned 10.1% over the past year.

Return vs Market: 543748 exceeded the Indian Market which returned -0.5% over the past year.

Price Volatility

Is 543748's price volatile compared to industry and market?
543748 volatility
543748 Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement6.8%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.6%

Stable Share Price: 543748 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 543748's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20192,095Hetal Galawww.aartipharmalabs.com

Aarti Pharmalabs Limited, together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system (CNS) agents, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects.

Aarti Pharmalabs Limited Fundamentals Summary

How do Aarti Pharmalabs's earnings and revenue compare to its market cap?
543748 fundamental statistics
Market cap₹66.97b
Earnings (TTM)₹2.49b
Revenue (TTM)₹20.57b

26.9x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543748 income statement (TTM)
Revenue₹20.57b
Cost of Revenue₹11.42b
Gross Profit₹9.15b
Other Expenses₹6.65b
Earnings₹2.49b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)27.51
Gross Margin44.47%
Net Profit Margin12.12%
Debt/Equity Ratio20.8%

How did 543748 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

13%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/16 06:37
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aarti Pharmalabs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.